In what has already been tagged as a “game-changer” for cancer treatment, the potent once-a-day tablet known as divarasib has continued to impress at Phase 1b trial stage, outperforming not just current therapies but its previous trial results.Continue ReadingCategory: Medical, ScienceTags: Peter MacCallum Cancer Centre, Cancer, Immunotherapy, Treatment, Drugs, Tumors, Research
Once-a-day pill for stubborn cancer delivers a 62.5% positive response
Posted by ArielTechGeek 511 days ago (https://newatlas.com)
Who Voted for this Story
Clickiz.com is a social bookmarking place where you can share, find & discuss the best news around on most topics. We focus on hi-tech reviews, gadgets and geekery but we like almost anything that's awesome, appealing and thought-provoking! er6i9ds5mz
a
adventure
apps
architects
architecture
best
chrome
compelling
comprehensive
design
electric
follow
fun
game
games
google
guide
hidden
home
hosting
house
ios
its
list
london
mysql
nikon
olympics
photo
plenty
projector
providers
save
secret
studio
text
the
top
tops
view
Comments